These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37111119)

  • 1. Safety and Suitability of an Infant Formula Manufactured from Extensively Hydrolysed Protein in Healthy Term Infants.
    Otten L; Schelker E; Petersen H; Nomayo A; Fleddermann M; Arendt BM; Britzl T; Haberl EM; Jochum F;
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Tolerance of an Infant Formula Manufactured from Extensively Hydrolysed Protein in Healthy Term Infants.
    Otten L; Schelker E; Petersen H; Nomayo A; Conzade R; Günther J; Grieger A; Jochum F; On Behalf Of The Hasi Study Group
    Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a partially hydrolysed formula based on rice protein in the treatment of infants with cow's milk protein allergy.
    Reche M; Pascual C; Fiandor A; Polanco I; Rivero-Urgell M; Chifre R; Johnston S; Martín-Esteban M
    Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 1):577-85. PubMed ID: 20337976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.
    Osborn DA; Sinn J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003664. PubMed ID: 17054180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant formulas containing hydrolysed protein for prevention of allergic disease.
    Osborn DA; Sinn JK; Jones LJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003664. PubMed ID: 30338526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants.
    Rigo J; Schoen S; Verghote M; van Overmeire B; Marion W; Abrahamse-Berkeveld M; Alliet P
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31331065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolyzed Formula With Reduced Protein Content Supports Adequate Growth: A Randomized Controlled Noninferiority Trial.
    Ahrens B; Hellmuth C; Haiden N; Olbertz D; Hamelmann E; Vusurovic M; Fleddermann M; Roehle R; Knoll A; Koletzko B; Wahn U; Beyer K
    J Pediatr Gastroenterol Nutr; 2018 May; 66(5):822-830. PubMed ID: 29216020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Suitability of Infant Formula Manufactured from Extensively Hydrolyzed Whey Protein Compared to Intact Protein: A Combined Analysis of Two Randomized Controlled Studies.
    Fleddermann M; Knoll A; Koletzko B
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial.
    Picaud JC; Pajek B; Arciszewska M; Tarczón I; Escribano J; Porcel R; Adelt T; Hassink E; Rijnierse A; Abrahamse-Berkeveld M; Korczowski B; On Behalf Of The Tenuto Study Group
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32668666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a new extensively hydrolyzed formula for infants with cow's milk protein allergy.
    Niggemann B; von Berg A; Bollrath C; Berdel D; Schauer U; Rieger C; Haschke-Becher E; Wahn U
    Pediatr Allergy Immunol; 2008 Jun; 19(4):348-54. PubMed ID: 18167160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
    Meli F; Puccio G; Cajozzo C; Ricottone GL; Pecquet S; Sprenger N; Steenhout P
    BMC Pediatr; 2014 Dec; 14():306. PubMed ID: 25527244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term effects of feeding hydrolyzed protein infant formulas on growth at < or = 6 y of age: results from the German Infant Nutritional Intervention Study.
    Rzehak P; Sausenthaler S; Koletzko S; Reinhardt D; von Berg A; Krämer U; Berdel D; Bollrath C; Grübl A; Bauer CP; Wichmann HE; Heinrich J;
    Am J Clin Nutr; 2009 Jun; 89(6):1846-56. PubMed ID: 19369380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and gut comfort of healthy term infants exclusively fed with a partially hydrolysed protein-based infant formula: a randomized controlled double-blind trial.
    Kantaras P; Kokkinopoulou A; Hageman JHJ; Hassapidou M; Androutsos O; Kanaki M; Bovee-Oudenhoven I; Karaglani E; Kontochristopoulou AM; Bos R; Manios Y
    Front Pediatr; 2024; 12():1328709. PubMed ID: 38827219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and tolerance of formula with lactoferrin in infants through one year of age: double-blind, randomized, controlled trial.
    Johnston WH; Ashley C; Yeiser M; Harris CL; Stolz SI; Wampler JL; Wittke A; Cooper TR
    BMC Pediatr; 2015 Nov; 15():173. PubMed ID: 26547414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of hydrolyzed protein infant formulas on growth--extended follow-up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study.
    Rzehak P; Sausenthaler S; Koletzko S; Reinhardt D; von Berg A; Krämer U; Berdel D; Bollrath C; Grübl A; Bauer CP; Wichmann HE; Heinrich J;
    Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1803S-1807S. PubMed ID: 21849601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.
    Osborn DA; Sinn J
    Cochrane Database Syst Rev; 2003; (4):CD003664. PubMed ID: 14583987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up.
    Scalabrin D; Harris C; Johnston WH; Berseth CL
    Eur J Pediatr; 2017 Feb; 176(2):217-224. PubMed ID: 27975116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cow's milk-specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula.
    Nentwich I; Michková E; Nevoral J; Urbanek R; Szépfalusi Z
    Allergy; 2001 Dec; 56(12):1144-56. PubMed ID: 11736743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmed Hypoallergenicity of a Novel Whey-Based Extensively Hydrolyzed Infant Formula Containing Two Human Milk Oligosaccharides.
    Nowak-Wegrzyn A; Czerkies L; Reyes K; Collins B; Heine RG
    Nutrients; 2019 Jun; 11(7):. PubMed ID: 31248026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.